Can a stronger anti-clot drug cut stroke risk? new trial aims to find out.
NCT ID NCT06591338
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study compares two drug combinations—aspirin plus ticagrelor versus aspirin plus clopidogrel—in people who recently had a minor stroke or transient ischemic attack (TIA) caused by a large blood vessel blockage. The goal is to see which combo better prevents new strokes and heart attacks over three months. About 900 adults aged 18–75 will take one of the two treatments within 24 hours of their first event, and researchers will track bleeding risks and other side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kafr Elsheikh University Hospital
RECRUITINGKafr ash Shaykh, 33511, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.